First Time Loading...
B

Brooklyn Immunotherapeutics Inc
NASDAQ:BTX

Watchlist Manager
Brooklyn Immunotherapeutics Inc
NASDAQ:BTX
Watchlist
Price: 0.2051 USD 0.05% Market Closed
Updated: May 21, 2024

Brooklyn Immunotherapeutics Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Brooklyn Immunotherapeutics Inc
Selling, General & Administrative Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
B
Brooklyn Immunotherapeutics Inc
NASDAQ:BTX
Selling, General & Administrative
-$6.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Selling, General & Administrative
-$13B
CAGR 3-Years
-2%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Selling, General & Administrative
-$6.1B
CAGR 3-Years
-6%
CAGR 5-Years
-8%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Selling, General & Administrative
-$6.7B
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Selling, General & Administrative
-$1.2B
CAGR 3-Years
-17%
CAGR 5-Years
-17%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Selling, General & Administrative
-$2.7B
CAGR 3-Years
-25%
CAGR 5-Years
-12%
CAGR 10-Years
-23%

See Also

What is Brooklyn Immunotherapeutics Inc's Selling, General & Administrative?
Selling, General & Administrative
-6.1m USD

Based on the financial report for Dec 31, 2020, Brooklyn Immunotherapeutics Inc's Selling, General & Administrative amounts to -6.1m USD.

What is Brooklyn Immunotherapeutics Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 1Y
54%

Over the last year, the Selling, General & Administrative growth was 54%.